Wednesday 4 January 2017

Research focused on the Melanoma Diagnostic Tests - Medical Devices Pipeline Assessment, 2016




"The Report Melanoma Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

GlobalData's Medical Devices sector report, Melanoma Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Melanoma Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Melanoma Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.


Scope

- Extensive coverage of the Melanoma Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Melanoma Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Melanoma Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
Get Sample Copy Of This Report @

Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Introduction 10
2.1 Melanoma Diagnostic Tests Overview 10
3 Products under Development 11
3.1 Melanoma Diagnostic Tests - Pipeline Products by Stage of Development 11
3.2 Melanoma Diagnostic Tests - Pipeline Products by Territory 12
3.3 Melanoma Diagnostic Tests - Pipeline Products by Regulatory Path 13
3.4 Melanoma Diagnostic Tests - Pipeline Products by Estimated Approval Date 14
3.5 Melanoma Diagnostic Tests - Ongoing Clinical Trials 15
4 Melanoma Diagnostic Tests - Pipeline Products under Development by Companies 16
4.1 Melanoma Diagnostic Tests Companies - Pipeline Products by Stage of Development 16
4.2 Melanoma Diagnostic Tests - Pipeline Products by Stage of Development 18
5 Melanoma Diagnostic Tests Companies and Product Overview 20
5.1 Abbott Diagnostics Company Overview 20
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 20
5.2 Adaptive Biotechnologies Corporation Company Overview 22
5.2.1 Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 22
5.3 Agilent Technologies, Inc. Company Overview 23
5.3.1 Agilent Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.4 BioMark Diagnostics Inc. Company Overview 25
5.4.1 BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.5 BioMarker Strategies, LLC Company Overview 26
5.5.1 BioMarker Strategies, LLC Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 Biosceptre (Aust) Pty Ltd Company Overview 28
5.6.1 Biosceptre (Aust) Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
5.7 Bio-Techne Corp Company Overview 29
5.7.1 Bio-Techne Corp Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 Boston University Company Overview 31
5.8.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 31
5.9 Ceres Nanosciences, Inc. Company Overview 32
5.9.1 Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.10 Dana-Farber Cancer Institute, Inc. Company Overview 33
5.10.1 Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.11 Digna Biotech, S.L. Company Overview 34
5.11.1 Digna Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 34
5.12 Exosomics Siena SpA Company Overview 35
5.12.1 Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview 35
5.13 Genentech, Inc. Company Overview 36
5.13.1 Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.14 Genomic Health, Inc. Company Overview 37
5.14.1 Genomic Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.15 Hospital Universitario Cruces Company Overview 39
5.15.1 Hospital Universitario Cruces Pipeline Products & Ongoing Clinical Trials Overview 39
5.16 Hummingbird Diagnostics GmbH Company Overview 40
5.16.1 Hummingbird Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 4

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

No comments:

Post a Comment